Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace's Head of Insights Lori Ellis and Tom ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Cybersecurity must be a top priority for organizations in drug discovery/development due to the significant risks, including ...

The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the FDA, experts say the cuts could drive uncertainty and delay regulatory ...

Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Year-over-year BioSpace data shows there were fewer job postings live on the website in the fourth quarter of 2024, and the ...

Biogen and Eisai have spent much of Leqembi’s launch convincing physicians and patients that it’s safe to treat Alzheimer’s ...

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...